EFDID: 295561EFD: View Filing

Issuer: INNOVATE BIOPHARMACEUTICALS, INC. (0001551986) - D

Accession: 0001551986-18-000043 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001551986
  • Entity Name:
    INNOVATE BIOPHARMACEUTICALS, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    8480 HONEYCUTT ROAD
    SUITE 120
    RALEIGH, NC 27615
  • Persons:
    Related Persons 7
    Jay Madan
    Executive Officer, Director
    Sandeep Laumas
    Executive Officer, Director
    Christopher Prior
    Executive Officer, Director
    Roy Proujansky
    Director
    Lorin Johnson
    Director
    Anthony Maida
    Director
    Saira Ramasastry
    Director
EDGAR: Offering Information
  • Accession Date:
    10/18/2018
  • First Sale Date:
    10/04/2018
  • Offering Amount:
    $5,196,667
  • Amount Sold:
    $5,196,667
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Debt
  • Sales Clarification:
    Total Offering Amount represents the total principal amount of a senior convertible note issued pursuant to an exchange agreement for a prior senior note.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
INNOVATE BIOPHARMACEUTICALS, INC./s/ Jay MadanJay MadanPresident2018-10-18